首页> 外文期刊>Journal of bacteriology >A Novel Mechanism for Desulfation of Mucin: Identification and Cloning of a Mucin-Desulfating Glycosidase (Sulfoglycosidase) from Prevotella Strain RS2
【24h】

A Novel Mechanism for Desulfation of Mucin: Identification and Cloning of a Mucin-Desulfating Glycosidase (Sulfoglycosidase) from Prevotella Strain RS2

机译:粘蛋白脱硫的一种新机制:鉴定和克隆了普氏杆菌RS2的粘蛋白脱硫糖苷酶(磺基糖苷酶)。

获取原文
           

摘要

A novel enzyme which may be important in mucin degradation has been discovered in the mucin-utilizing anaerobe Prevotella strain RS2. This enzyme cleaves terminal 2-acetamido-2-deoxy-β-d-glucopyranoside 6-sulfate (6-SO3-GlcNAc) residues from sulfomucin and from the model substrate 4-nitrophenyl 2-acetamido-2-deoxy-β-d-glucopyranoside 6-sodium sulfate. The existence of this mucin-desulfating glycosidase (sulfoglycosidase) suggests an alternative mechanism by which this bacterium may desulfate sulfomucins, by glycosidic removal of a sulfated sugar from mucin oligosaccharide chains. Previously, mucin desulfation was thought to take place by the action of a specific desulfating enzyme, which then allowed glycosidases to remove desulfated sugar. Sulfate removal from sulfomucins is thought to be a rate-limiting step in mucin degradation by bacteria in the regions of the digestive tract with a significant bacterial flora. The sulfoglycosidase was induced by growth of the Prevotella strain on mucin and was purified 284-fold from periplasmic extracts. Tryptic digestion and sequencing of peptides from the 100-kDa protein enabled the sulfoglycosidase gene to be cloned and sequenced. Active recombinant enzyme was made in an Escherichia coli expression system. The sulfoglycosidase shows sequence similarity to hexosaminidases. The only other enzyme that has been shown to remove 6-SO3-GlcNAc from glycoside substrates is the human lysosomal enzyme β-N-acetylhexosaminidase A, point mutations in which cause the inheritable, lysosomal storage disorder Tay-Sachs disease. The human enzyme removes GlcNAc from glycoside substrates also, in contrast to the Prevotella enzyme, which acts on a nonsulfated substrate at a rate that is only 1% of the rate observed with a sulfated substrate.
机译:在利用粘蛋白的厌氧菌 Prevotella 菌株RS2中发现了一种对粘蛋白降解可能很重要的新型酶。该酶从磺胺嘧啶和模型底物4-硝基苯基2-乙酰氨基-切割末端2-乙酰氨基-2-脱氧-β-d-吡喃葡萄糖苷6-硫酸盐(6-SO 3 -GlcNAc)残基。 2-脱氧-β-d-吡喃葡萄糖苷6-硫酸钠。这种粘蛋白脱硫糖苷酶(磺基糖苷酶)的存在提示了另一种机制,该细菌可以通过从粘蛋白寡糖链中糖苷化地去除硫酸糖来使磺粘菌素脱硫。以前,粘蛋白脱硫被认为是通过特定的脱硫酶的作用进行的,然后该酶使糖苷酶去除脱硫的糖。人们认为,从硫菌素中去除硫酸盐是细菌在具有大量细菌菌群的消化道区域进行粘蛋白降解的限速步骤。磺基糖苷酶是由 Prevotella 菌株在粘蛋白上的生长诱导的,并从周质提取物中纯化了284倍。对100-kDa蛋白的肽进行胰蛋白酶消化和测序,可以对磺基糖苷酶基因进行克隆和测序。在大肠杆菌表达系统中制备了活性重组酶。磺基糖苷酶显示与己糖胺酶的序列相似性。已显示从糖苷底物中去除6-SO 3 -GlcNAc的唯一其他酶是人溶酶体酶β- N -乙酰基己糖胺酶A,其点突变可导致遗传性溶酶体贮积病Tay-Sachs病。与 Prevotella 酶相反,人类酶也从糖苷底物中去除GlcNAc,后者以非硫酸化底物的作用速率仅为硫酸化底物的1%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号